DBD

DBD (DBD) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 45,750 VND, little changed on the session, giving a market capitalization of 4.8 trillion VND.

On valuation, DBD trades at a price-to-earnings ratio of 16.6 and a price-to-book of 2.7. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 16.0% points to solid profitability relative to the company's equity base, above the sector average of 11.3%. Trailing earnings per share stand at 3,082 VND.

Aveluro tracks 5 news items mentioning DBD, where recent coverage skews positive (80% of articles). The most recent catalyst was an earnings beat event — "MWG Q3 2026 Earnings: Mobile World Pre-Tax Profit Up 95% to VND 4,239B". Aveluro's composite model rates DBD 10.0/10 (Very Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around DBD include 4 notable classified events. On Oct 28, 2026, an earnings beat was reported: Mobile World (MWG) reported Q3 2026 pre-tax profit of VND 4,239 billion, up 95% year on year, lifting nine-month profit to VND 11,600 billion (+89%). On Aug 16, 2026, a dividend announcement was reported: Bidiphar (DBD) will pay a 20% cash dividend for 2025, with the record date set for August 28, 2026, and payment on October 1, 2026. On May 13, 2026, a market event was reported: DBD partners with Citek to launch a comprehensive digital transformation project, upgrading to SAP S/4HANA Private Cloud and implementing CSV, IFRS, and BI systems. On Apr 17, 2026, a market event was reported: Bidiphar (DBD) will propose a private placement of 23.3 million shares to raise approximately VND 1,165 billion at a minimum price of VND 50,000 per share, targeting up to five professional investors.

The overall tone of recent coverage is positive, with 3 of 4 events carrying bullish sentiment.